The European Union is in talks to procure some 100 million additional doses of the Pfizer/BioNTech coronavirus vaccine as part of a potential new contract, French Secretary of State for European Affairs Clément Beaune said Tuesday.
"There are European discussions at this very moment, which we are supporting, to order additional doses that will benefit France, as well as other countries," Beaune told BFM TV. "There are no definitive numbers, but it could be around a hundred million more," Beaune added.
While the Secretary of State for European Affairs denied that the EU has experienced a shortage in vaccine supplies, he confirmed that discussions are ongoing to procure more doses.
Speaking on Tuesday, European Council President Charles Michel said that the distribution of the vaccine across the EU has posed a "tremendous challenge," but asserted that European authorities are "fully mobilised" with member states in order to ensure that doses are deployed.
"Before the end of January, EU leaders will have another video conference to discuss again the Covid-19 crisis and the vaccine roll-out," Michel added.
In his interview with BFM on Tuesday, Secretary of State Beaune noted that the EU has so far "signed contracts with six major vaccine companies," adding that one million doses had arrived in France on Tuesday evening.
CNN has reached out to BioNTech for comment and is awaiting a response.